Why is Fulcrum Therapeutics stock collapsing today?

Chronological Source Flow
Back

AI Fusion Summary

Penguin Solutions shares rise sharply after announcing stronger-than-expected earnings and a new product launch, while Fulcrum Therapeutics shares fall sharply following a failed clinical trial and regulatory concerns, causing market volatility.
Community Comments
Loading updates...
0